Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05668806

RWE Study in the Treatment of Cervical Lesions of Various Etiology

Conditions: Cervical Lesion, Vaginal Bleeding

Sex: Female
Ages: 18 Years – N/A
Enrollment: 345
Sponsor: Perfect Care Distribution

Location: Romania

Summary

The aim of the study was to assess the post-market performance and tolerability of Cerviron® ovules in the treatment and management of cervical lesions of different etiologies. The study included clinical data related to aspect of lesions performed during routine colposcopy exams, the degree of re-epithelialization of the cervical mucosa, vaginal pH, pain level, and vaginal bleeding level.

Eligibility Criteria

Inclusion Criteria:Patients with a clearly diagnosed non-infectious gynecological disease and patients with traumatic or surgical lesions.Patients with either of the following medical history: trauma of the cervix, pain, bleeding after sexual intercourse, postpartum injuries or postoperative cervical lesions.Exclusion Criteria:Patients with cervical cancer.Patients with vulvar cancer

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05668806). StuddyBuddy aggregates publicly available trial information.